Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive Disorders

Clinical trial NCT04295681 · COMPLETED

Trial details

NCT number: NCT04295681
Sponsor: Materia Medica Holding
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cognitive Disorders

Start date: 2019-12-12
Primary completion: 2023-02-07
Enrollment: 246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.